BLFS Biolife Solutions Inc
Price (delayed)
$23.36
Market cap
$1.08B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.35
Enterprise value
$1.09B
BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Its products and services portfolio includes its proprietary CryoStor® freeze media, HypoThermosol® shipping and storage
Highlights
The debt has declined by 19% year-on-year and by 12% since the previous quarter
BLFS's gross margin is up by 10% year-on-year and by 9% since the previous quarter
The EPS has grown by 26% year-on-year but it has declined by 3.1% since the previous quarter
BLFS's net income is down by 17% since the previous quarter but it is up by 12% year-on-year
The company's revenue fell by 17% YoY
The equity has contracted by 9% YoY and by 3.6% from the previous quarter
Key stats
What are the main financial stats of BLFS
Market
Valuations
Earnings
Shares outstanding
46.14M
Market cap
$1.08B
Enterprise value
$1.09B
Price to book (P/B)
3.35
Price to sales (P/S)
8.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.66
Revenue
$126.12M
EBIT
-$71.7M
EBITDA
-$61.02M
Free cash flow
-$7.81M
Per share
Balance sheet
Liquidity
EPS
-$1.35
Free cash flow per share
-$0.17
Book value per share
$6.98
Revenue per share
$2.74
TBVPS
$2.84
Total assets
$374.98M
Total liabilities
$53.53M
Debt
$35.96M
Equity
$321.44M
Working capital
$57.38M
Debt to equity
0.11
Current ratio
2.86
Quick ratio
1.69
Net debt/EBITDA
-0.23
Margins
Efficiency
Dividend
EBITDA margin
-48.4%
Gross margin
38.3%
Net margin
-58.2%
Operating margin
-45.1%
Return on assets
-18.4%
Return on equity
-22.2%
Return on invested capital
-54.9%
Return on capital employed
-20.8%
Return on sales
-56.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BLFS stock price
How has the Biolife Solutions stock price performed over time
Intraday
-0.38%
1 week
0.73%
1 month
-9.63%
1 year
83.5%
YTD
43.75%
QTD
9.01%
Financial performance
How have Biolife Solutions's revenue and profit performed over time
Revenue
$126.12M
Gross profit
$48.35M
Operating income
-$56.86M
Net income
-$73.45M
Gross margin
38.3%
Net margin
-58.2%
BLFS's operating income is up by 33% YoY and by 13% QoQ
The operating margin has increased by 19% YoY and by 13% from the previous quarter
The net margin has declined by 18% since the previous quarter and by 6% year-on-year
BLFS's net income is down by 17% since the previous quarter but it is up by 12% year-on-year
Growth
What is Biolife Solutions's growth rate over time
Valuation
What is Biolife Solutions stock price valuation
P/E
N/A
P/B
3.35
P/S
8.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.66
The EPS has grown by 26% year-on-year but it has declined by 3.1% since the previous quarter
BLFS's price to book (P/B) is 40% higher than its last 4 quarters average of 2.4 but 4% lower than its 5-year quarterly average of 3.5
The equity has contracted by 9% YoY and by 3.6% from the previous quarter
The P/S is 45% higher than the last 4 quarters average of 5.9 but 21% lower than the 5-year quarterly average of 10.9
The company's revenue fell by 17% YoY
Efficiency
How efficient is Biolife Solutions business performance
The ROIC has contracted by 28% from the previous quarter and by 12% YoY
Biolife Solutions's return on assets has decreased by 21% QoQ
The ROE has contracted by 19% from the previous quarter
The return on sales has declined by 18% since the previous quarter and by 4.4% year-on-year
Dividends
What is BLFS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BLFS.
Financial health
How did Biolife Solutions financials performed over time
The total liabilities has decreased by 34% YoY and by 22% from the previous quarter
The total assets has decreased by 13% YoY and by 7% QoQ
The debt is 89% smaller than the equity
The debt has declined by 19% year-on-year and by 12% since the previous quarter
Biolife Solutions's debt to equity has decreased by 15% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.